Urges Japan to honor its commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals by: (1) reducing regulatory barriers to the approval and adoption of new medical technologies; (2) meeting or exceeding agency performance goals for premarket approvals and adopting an appropriate, risk-based postmarket system consistent with globally accepted practices; (3) promoting pricing policies that encourage innovation and eliminating reimbursement policies based on inappropriate comparisons to markets outside Japan; (4) implementing fair and open processes and rules that do not disproportionately harm U.S. medical technology products; and (5) providing opportunities for consultation with trading partners.
Referred to the Committee on Foreign Relations. (text of measure as introduced: CR S13401-13402)
Introduced in House
Introduced in House
Referred to the House Committee on Ways and Means.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line